SCHEMBL3160362

SCHEMBL3160362

CCCCCCC/C=[C]\C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.52
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
PPARG P37231 3/20 0.50
PPARD Q03181 3/20 0.50
PPARA Q07869 3/20 0.50
TOP1 P11387 3/20 0.50
MAPT P10636 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
APEX1 P27695 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3170033 1.00 EP300 (0.52) EP300TERTPTPN1PPARGPPARD
SCHEMBL9274603 1.00 EP300 (0.52) EP300TERTPTPN1PPARGPPARD
SCHEMBL3160330 1.00 EP300 (0.52) EP300TERTPTPN1PPARGPPARD
SCHEMBL3160365 1.00 EP300 (0.52) EP300TERTPTPN1PPARGPPARD
SCHEMBL3170026 1.00 EP300 (0.52) EP300TERTPTPN1PPARGPPARD
SCHEMBL3160326 1.00 EP300 (0.52) EP300TERTPTPN1PPARGPPARD
SCHEMBL3177068 0.98 EP300 (0.48) EP300TERTPTPN1PPARGPPARD
SCHEMBL3177074 0.98 EP300 (0.48) EP300TERTPTPN1PPARGPPARD
SCHEMBL3165888 0.91
SCHEMBL3165885 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100011656-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS BASF SE (DE) 2010-01-21 US disclosed
US-20090124732-A1 Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups BASF AKTIENGESELLSCHAFT (DE) 2009-05-14 US disclosed
US-7521556-B2 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides BASF SE (DE) 2009-04-21 US disclosed
EP-2007857-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS BASF SE (DE) 2008-12-31 EP disclosed
EP-1513841-B1 1,6,9,14-TETRASUBSTITUTED TERRYLENE TETRACARBOXYLIC ACID DIIMIDES BASF SE (DE) 2008-05-14 EP disclosed
WO-2007099059-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS BASF SE (DE) 2007-09-07 WO disclosed
EP-1819678-A1 RYLENE TETRACARBOXYLIC ACID DIIMIDES SUBSTITUTED BY CYCLIC AMINO GROUPS BASF AKTIENGESELLSCHAFT (DE) 2007-08-22 EP disclosed
WO-2006058674-A1 RYLENE TETRACARBOXYLIC ACID DIIMIDES SUBSTITUTED BY CYCLIC AMINO GROUPS BASF AKTIENGESELLSCHAFT (DE) 2006-06-08 WO disclosed
US-20050222416-A1 1,6,9,14-teltrasubstituted terrylene tetracarboxylic diimides BASF AKTIENGESELLSCHAFT (DE) 2005-10-06 US disclosed
US-6184378-B1 PIGMENTS, LASER DYES AND PRECURSORS FOR PREPARING FLUORESCENT DYES, POLYMERIC COLORANTS, BASF AKTIENGESELLSCHAFT (DE) 2001-02-06 US disclosed
EP-0869959-B1 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS BASF AG (DE) 2000-05-17 EP disclosed
US-6063181-A 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids BASF AKTIENGESELLSCHAFT (DE) 2000-05-16 US disclosed
EP-0869959-A1 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS BASF AKTIENGESELLSCHAFT (DE) 1998-10-14 EP disclosed
WO-1997022608-A1 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS BASF AKTIENGESELLSCHAFT (DE) 1997-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124732-A1 Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups NR1I3, NR1I2, NR1H3 EP300 2502/4885TERT 3176/4885PTPN1 633/4885
US-20050222416-A1 1,6,9,14-teltrasubstituted terrylene tetracarboxylic diimides CNR2, CNR1, CBR1 EP300 1210/4885TERT 1266/4885PTPN1 1867/4885
US-20100011656-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS RPL22, PROX1, RPL29 EP300 3799/4885TERT 655/4885PTPN1 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.